FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1141603003: Darunavir propylene glycolate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4534760014 Darunavir propylene glycolate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4534761013 Darunavir propylene glycolate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Darunavir propylene glycolate Is a Carbamate ester (substance) true Inferred relationship Some
Darunavir propylene glycolate Is a Sulfonamide (substance) true Inferred relationship Some
Darunavir propylene glycolate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protease inhibitor (disposition) true Inferred relationship Some
Darunavir propylene glycolate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Darunavir (substance) true Inferred relationship Some
Darunavir propylene glycolate Is a Protease inhibitor true Inferred relationship Some
Darunavir propylene glycolate Is a Anti-infective agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Darunavir (as darunavir propylene glycolate) 800 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Darunavir propylene glycolate Inferred relationship Some 1
Product containing precisely darunavir (as darunavir propylene glycolate) 600 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Darunavir propylene glycolate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start